Patients with chronic kidney disease (CKD) frequently experience unpleasant symptoms.
These can be gastrointestinal (constipation, nausea, vomiting and diarrhoea), psychological …

Environmental changes can induce diversity shifts within ecosystems that affect interactions
between species. Similarly, the development of kidney disease induces shifts within the …

Diabetic kidney disease is a major cause of renal failure that urgently necessitates a
breakthrough in disease management. Here we show using untargeted metabolomics that …

Dyslipidemia is a common nutritional and metabolic disorder in patients with chronic kidney
disease. Accumulating evidence supports the hypothesis that prolonged metabolic …

In chronic kidney disease (CKD), accumulation of uremic toxins is associated with an
increased risk of CKD progression. Some uremic toxins result from nutrient processing by …

Background Developing strategies for managing coronary artery calcification (CAC) in
patients with CKD is an important clinical challenge. Experimental studies have …

Chronic kidney disease (CKD) is characterized by the retention of a myriad of solutes termed
uraemic (or uremic) toxins, which inflict damage to several organs, including the …

Cardiovascular disease (CVD) is highly prevalent in the setting of chronic kidney disease
(CKD). Such coexistence of CVD and CKD—the so-called “cardiorenal or renocardiac …

Chronic kidney disease (CKD) is a worldwide health problem, because it is one of the most
common complications of metabolic diseases including obesity and type 2 diabetes …

Background Uremic toxicity may play a role in the elevated risk of developing cognitive
impairment found among patients with CKD. Some uremic toxins, like indoxyl sulfate, are …